[Sarcopenia: a new geriatric hot topic]
- PMID: 19994668
[Sarcopenia: a new geriatric hot topic]
Abstract
Highly prevalent in the population older than 65 years, and leading to poor outcomes (functional decline and its related consequences), sarcopenia does not benefit yet either of a clear understanding of its patho-physiology. Its origin, its risk factors, its clinical presentation will be detailed. The diagnosis of sarcopenia imposes a clear identification of the risk factors, a specific muscular assessment, a pragmatic clinical approach. The treatment is based on nutritional supplements and/or drugs which to be active need to be associated to physical exercises of moderate intensity. Geriatricians are expecting new therapy to delay the consequences of sarcopenia, e.g. frailty and inability in daily living.
Similar articles
-
Understanding sarcopenia as a geriatric syndrome.Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):1-7. doi: 10.1097/MCO.0b013e328333c1c1. Curr Opin Clin Nutr Metab Care. 2010. PMID: 19915458 Review.
-
Role of adapted physical activity to prevent the adverse effects of the sarcopenia. A pilot study.Ital J Anat Embryol. 2008 Oct-Dec;113(4):217-25. Ital J Anat Embryol. 2008. PMID: 19507462
-
[The emergent role of sarcopenia: Preliminary Report of the Observatory of Sarcopenia of the Spanish Society of Geriatrics and Gerontology].Rev Esp Geriatr Gerontol. 2011 Mar-Apr;46(2):100-10. doi: 10.1016/j.regg.2010.11.004. Epub 2011 Jan 8. Rev Esp Geriatr Gerontol. 2011. PMID: 21216498 Review. Spanish.
-
[Diagnosis, prevention and treatment of sarcopenia].Pol Merkur Lekarski. 2011 Apr;30(178):274-6. Pol Merkur Lekarski. 2011. PMID: 21595174 Review. Polish.
-
Sarcopenia in the elderly: basic and clinical issues.Geriatr Gerontol Int. 2012 Jul;12(3):388-96. doi: 10.1111/j.1447-0594.2012.00851.x. Epub 2012 Apr 25. Geriatr Gerontol Int. 2012. PMID: 22530761 Review.